EXPRESSION THERAPEUTICS

Company Information

Company Name
EXPRESSION THERAPEUTICS
Address
1860 Montreal Road
TUCKER, GA, 30084-5709
Phone
n/a
URL
n/a
DUNS
361719755
Number of Employees
n/a
Hubzone Owned:
N
Minority Owned:
N
Woman Owned:
N

Award Totals

PROGRAM/PHASE
AWARD AMOUNT ($)
NUMBER OF AWARDS
SBIR Phase I
$1,061,208.00
3
SBIR Phase II
$2,969,392.00
2
STTR Phase I
$200,000.00
2
STTR Phase II
$2,586,823.00
2
Chart code to be here

Award List

  1. Ex Vivo Gene Therapy of Hemophilia A

    Amount: $100,000.00

    DESCRIPTION (provided by applicant): Hemophilia A is a bleeding disorder caused by mutations within the factor VIII (fVIII) gene that result in a deficiency of circulating fVIII activity. Current trea ...

    STTR Phase I 2006 Department of Health and Human Services
  2. High Expression Recombinant Factor VIII

    Amount: $100,000.00

    DESCRIPTION (provided by applicant): The hemophilias (A and B) are rare bleeding disorders toward which much scientific and medical effort has been devoted. In 1840, blood transfusion was used for the ...

    STTR Phase I 2008 Department of Health and Human Services
  3. Ex Vivo Gene Therapy for Hemophilia A

    Amount: $1,126,694.00

    DESCRIPTION (provided by applicant): Hemophilia A is a congenital bleeding disorder caused by genetic mutations affecting a plasma protein, termed factor VIII (fVIII), whose function is to facilitate ...

    STTR Phase II 2009 Department of Health and Human Services
  4. High Expression Recombinant Factor VIII

    Amount: $1,460,129.00

    DESCRIPTION (provided by applicant): The hemophilias (A and B) are rare bleeding disorders toward which much scientific and medical effort has been devoted. In 1840, blood transfusion was used for the ...

    STTR Phase II 2010 Department of Health and Human Services
  5. Development of a novel production platform for complex recombinant biotherapeutic

    Amount: $296,320.00

    DESCRIPTION (provided by applicant): The manufacturing of recombinant protein-based biopharmaceuticals is a complex, labor and capital intensive endeavor. It currently is accepted that the use of mamm ...

    SBIR Phase I 2012 Department of Health and Human Services
  6. Bioengineered factor VIII gene therapy for hemophilia A

    Amount: $378,456.00

    DESCRIPTION (provided by applicant): The overall goal of this proposal is to conduct late-stage preclinical studies to support a pilot clinical trial of hematopoietic stem cell transplantaton gene the ...

    SBIR Phase I 2012 Department of Health and Human Services
  7. Manufacturing Process Development for Bioengineered FVIII

    Amount: $386,432.00

    DESCRIPTION (provided by applicant): The manufacturing of recombinant coagulation factor VIII is a complex, labor and capital intensive endeavor. Of the recombinant proteins currently marketed, coagul ...

    SBIR Phase I 2013 Department of Health and Human Services
  8. Bioengineered factor VIII gene therapy for hemophilia A

    Amount: $1,485,861.00

    DESCRIPTION (provided by applicant): The overall goal of this proposal is to conduct a gene therapy clinical trial incorporating genetically modified hematopoietic stem cells (HSCs) for persons with h ...

    SBIR Phase II 2014 Department of Health and Human Services
  9. Bioengineered Recombinant FVIII

    Amount: $1,483,531.00

    PROJECT SUMMARY/ABSTRACT The manufacturing of recombinant coagulation factor VIII is a complex, labor and capital intensive endeavor. Of the recombinant proteins currently marketed, coagulation factor ...

    SBIR Phase II 2014 Department of Health and Human Services

Agency Micro-sites


SBA logo

Department of Agriculture logo

Department of Commerce logo

Department of Defense logo

Department of Education logo

Department of Energy logo

Department of Health and Human Services logo

Department of Homeland Security logo

Department of Transportation logo

Enviromental Protection Agency logo

National Aeronautics and Space Administration logo

National Science Foundation logo
US Flag An Official Website of the United States Government